Chosa ApS
Advancing precision oncology through biology-driven platinum treatment selection technology.
Yleiskatsaus
- 3
- Työntekijät
- Tuntematon
- Liikevaihto
- 2022
- Perustettu
Kuvaus
CHOSA Oncology is a precision medicine company dedicated to improving cancer treatment outcomes through advanced biomarker-driven technologies. Their flagship product, Platin-DRP, analyzes gene expression from routine biopsies to predict a patient's likelihood of responding to platinum-based chemoth...